By Matt Tracy WASHINGTON, Dec 15 (Reuters) - Credit rating agency Fitch on Monday downgraded the credit ratings of insurance ...
Mark Cuban and Humana’s CEO Jim Rectin spoke about a potential partnership while speaking at the annual Forbes Healthcare ...
The insurer continues to try to prove that regulators acted arbitrarily in downgrading its quality scores for 2025, despite ...
Fitch cited concerns that Humana’s EBITDA-based margins are unlikely to recover to levels supporting previous ratings. The downgrade reflects elevated healthcare utilization across the sector and ...
Humana is again trying to win its lawsuit against the Centers for Medicare and Medicaid Services over its star ratings ...
Humana (HUM) stock has remained sideways for the year with the company lowering its full-year earnings outlook. While Humana ...
Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs ...
Humana (HUM) has been upgraded to Buy at Jefferies, driven by a significantly improved earnings outlook. Read more here.
Humana (HUM): Revisiting Valuation After Volatile Returns and Ongoing Medicare Advantage Uncertainty
Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap ...
Humana Inc. is working with billionaire Mark Cuban on a potential pharmacy partnership, Cuban and Humana’s chief executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results